Search research articles
Contact Us
Filters
Showing results (101-110 of 122) with videos related to
Page
of 13
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 20, 2011
Characterization of hepatic and intestinal glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDP-glucuronosyltransferase isoforms
Liangliang Zhu, Guangbo Ge, Hongbo Zhang, et al.
Molecular Pharmaceutics
|
June 1, 2016
Biosynthesis of Drug Glucuronide Metabolites in the Budding Yeast Saccharomyces cerevisiae
Shinichi Ikushiro, Miyu Nishikawa, Yuuka Masuyama, et al.
Molecular Pharmaceutics
|
February 10, 2018
Molecular Docking-Based Design and Development of a Highly Selective Probe Substrate for UDP-glucuronosyltransferase 1A10
Risto O Juvonen, Sanna Rauhamäki, Sami Kortet, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 16, 2014
A UGT2B10 splicing polymorphism common in african populations may greatly increase drug exposure
Stephen Fowler, Heidemarie Kletzl, Moshe Finel, et al.
Chemosphere
|
November 10, 2018
Endocrine activities and adipogenic effects of bisphenol AF and its main metabolite
Darja Gramec Skledar, Adriana Carino, Jurij Trontelj, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 30, 2008
Identification of hydroxywarfarin binding site in human UDP glucuronosyltransferase 1a10: phenylalanine90 is crucial for the glucuronidation of 6- and 7-hydroxywarfarin but not 8-hydroxywarfarin
Grover P Miller, Cheryl F Lichti, Agnieszka K Zielinska, et al.
Analytica Chimica Acta
|
March 14, 2021
A fluorescence-based microplate assay for high-throughput screening and evaluation of human UGT inhibitors
Qi-Hang Zhou, Xia Lv, Zhen-Hao Tian, et al.
International Journal of Biological Macromolecules
|
December 31, 2018
Inhibition of UGT1A1 by natural and synthetic flavonoids
Xin-Yu Liu, Xia Lv, Ping Wang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 12, 2014
A potential role for human UDP-glucuronosyltransferase 1A4 promoter single nucleotide polymorphisms in the pharmacogenomics of tamoxifen and its derivatives
Aleksandra K Greer, Centdrika R Dates, Athena Starlard-Davenport, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 3, 2018
A Novel Pathogenic <i>UGT1A1</i> Variant in a Sudanese Child with Type 1 Crigler-Najjar Syndrome
Walaa Elfar, Erkka Järvinen, Weizhen Ji, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 122) with videos related to
Sort By:
Page
of 13
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 20, 2011
Characterization of hepatic and intestinal glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDP-glucuronosyltransferase isoforms
Liangliang Zhu, Guangbo Ge, Hongbo Zhang, et al.
Molecular Pharmaceutics
|
June 1, 2016
Biosynthesis of Drug Glucuronide Metabolites in the Budding Yeast Saccharomyces cerevisiae
Shinichi Ikushiro, Miyu Nishikawa, Yuuka Masuyama, et al.
Molecular Pharmaceutics
|
February 10, 2018
Molecular Docking-Based Design and Development of a Highly Selective Probe Substrate for UDP-glucuronosyltransferase 1A10
Risto O Juvonen, Sanna Rauhamäki, Sami Kortet, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 16, 2014
A UGT2B10 splicing polymorphism common in african populations may greatly increase drug exposure
Stephen Fowler, Heidemarie Kletzl, Moshe Finel, et al.
Chemosphere
|
November 10, 2018
Endocrine activities and adipogenic effects of bisphenol AF and its main metabolite
Darja Gramec Skledar, Adriana Carino, Jurij Trontelj, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 30, 2008
Identification of hydroxywarfarin binding site in human UDP glucuronosyltransferase 1a10: phenylalanine90 is crucial for the glucuronidation of 6- and 7-hydroxywarfarin but not 8-hydroxywarfarin
Grover P Miller, Cheryl F Lichti, Agnieszka K Zielinska, et al.
Analytica Chimica Acta
|
March 14, 2021
A fluorescence-based microplate assay for high-throughput screening and evaluation of human UGT inhibitors
Qi-Hang Zhou, Xia Lv, Zhen-Hao Tian, et al.
International Journal of Biological Macromolecules
|
December 31, 2018
Inhibition of UGT1A1 by natural and synthetic flavonoids
Xin-Yu Liu, Xia Lv, Ping Wang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 12, 2014
A potential role for human UDP-glucuronosyltransferase 1A4 promoter single nucleotide polymorphisms in the pharmacogenomics of tamoxifen and its derivatives
Aleksandra K Greer, Centdrika R Dates, Athena Starlard-Davenport, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 3, 2018
A Novel Pathogenic <i>UGT1A1</i> Variant in a Sudanese Child with Type 1 Crigler-Najjar Syndrome
Walaa Elfar, Erkka Järvinen, Weizhen Ji, et al.
Page
of 13